CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K/A Event Shareholder vote results
- 8-K Event Material agreement · Bylaws or fiscal year change · Other events
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Auditor change
- 8-K/A Event Exhibits
- 10-K Report Annual Report
- 8-K Event Executive or director change · Other events
- 8-K Event Acquisition or sale completed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Director nominations · Other events
- 8-K Event Other events
Page 5 of 10 · 183 filings